Eli Lilly transfers commercialization rights for breast cancer drug in China amid generic competition - Reuters
Eli Lilly transfers commercialization rights for breast cancer drug in China amid generic competition Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxOU3c5a1lGUmk5eEU2TEMzYXhydlcwNXVfdGJ5OFM0cWRJbkk2VWpPRW1zY0hyZ0dwMF9ZX2xfNE9zR3NyNEJfVmJVRFp4X3FVRDZoQU83RDUyc1pwQjBxS2gtM1RjVTg3VE1zbWZtME9ZSEdKcW9sRmxqWlUwRGlRVXEzSE00WHRMS0FseUVwZEZaYkdHSjZpTnpsS21ncHV4Skc5T2JhWWViYld6Y0NtbGNoajJUV2pSMjdWaExxcEN6MFA2M1Bnd1FvRDNEdw?oc=5" target="_blank">Eli Lilly transfers commercialization rights for breast cancer drug in China amid generic competition</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMChina approves J&J psoriasis pill Icotyde, says drugmaker - Reuters
China approves J&J psoriasis pill Icotyde, says drugmaker Reuters
August 27, 2026 at 05:02 PMUS FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
August 28, 2026 at 10:16 PMRoche, Eli Lilly's Alzheimer's blood test gets FDA clearance - Reuters
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance Reuters
August 24, 2026 at 05:39 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMChina's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
August 27, 2026 at 03:47 AM